336 related articles for article (PubMed ID: 34601829)
1. Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis.
Pearson MM; Kim NJ; Berry K; Moon AM; Su F; Vutien P; Green PK; Williams EC; Ioannou GN
Hepatol Commun; 2021 Dec; 5(12):2080-2095. PubMed ID: 34601829
[TBL] [Abstract][Full Text] [Related]
2. Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis.
VoPham T; Cravero A; Feld LD; Green P; Feng Z; Berry K; Kim NJ; Vutien P; Mendoza JA; Ioannou GN
Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1069-1078. PubMed ID: 37255388
[TBL] [Abstract][Full Text] [Related]
3. Comparison of outcomes between patients with alcoholic cirrhosis and those with hepatitis C virus-related cirrhosis.
Toshikuni N; Izumi A; Nishino K; Inada N; Sakanoue R; Yamato R; Suehiro M; Kawanaka M; Yamada G
J Gastroenterol Hepatol; 2009 Jul; 24(7):1276-83. PubMed ID: 19486451
[TBL] [Abstract][Full Text] [Related]
4. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients.
Khan KN; Yatsuhashi H
Alcohol Alcohol; 2000; 35(3):286-95. PubMed ID: 10869250
[TBL] [Abstract][Full Text] [Related]
5. Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma.
Cabibbo G; Petta S; Barbara M; Attardo S; Bucci L; Farinati F; Giannini EG; Negrini G; Ciccarese F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Virdone R; Marra F; Mega A; Morisco F; Benvegnù L; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Colecchia A; Persico M; Craxì A; Trevisani F; Cammà C;
J Hepatol; 2017 Jul; 67(1):65-71. PubMed ID: 28192185
[TBL] [Abstract][Full Text] [Related]
6. Different patterns of decompensation in patients with alcoholic vs. non-alcoholic liver cirrhosis.
Wiegand J; Kühne M; Pradat P; Mössner J; Trepo C; Tillmann HL
Aliment Pharmacol Ther; 2012 Jun; 35(12):1443-50. PubMed ID: 22530565
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting.
Said A; Williams J; Holden J; Remington P; Musat A; Lucey MR
Clin Gastroenterol Hepatol; 2004 Oct; 2(10):928-34. PubMed ID: 15476157
[TBL] [Abstract][Full Text] [Related]
8. Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification.
Ioannou GN; Green P; Kerr KF; Berry K
J Hepatol; 2019 Sep; 71(3):523-533. PubMed ID: 31145929
[TBL] [Abstract][Full Text] [Related]
9. Association of Heavy Alcohol Intake and ALDH2 rs671 Polymorphism With Hepatocellular Carcinoma and Mortality in Patients With Hepatitis B Virus-Related Cirrhosis.
Tsai MC; Yang SS; Lin CC; Wang WL; Hsu YC; Chen YS; Hu JT; Lin JY; Yu ML; Lin CW
JAMA Netw Open; 2022 Jul; 5(7):e2223511. PubMed ID: 35877121
[TBL] [Abstract][Full Text] [Related]
10. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
11. Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
Marot A; Henrion J; Knebel JF; Moreno C; Deltenre P
PLoS One; 2017; 12(10):e0186715. PubMed ID: 29077714
[TBL] [Abstract][Full Text] [Related]
12. Effect of hepatitis C virus infection and abstinence from alcohol on survival in patients with alcoholic cirrhosis.
Serra MA; Escudero A; Rodríguez F; del Olmo JA; Rodrigo JM
J Clin Gastroenterol; 2003 Feb; 36(2):170-4. PubMed ID: 12544203
[TBL] [Abstract][Full Text] [Related]
13. Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.
Orman ES; Roberts A; Ghabril M; Nephew L; Desai AP; Patidar K; Chalasani N
JAMA Netw Open; 2019 Jun; 2(6):e196412. PubMed ID: 31251379
[TBL] [Abstract][Full Text] [Related]
14. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
15. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
[TBL] [Abstract][Full Text] [Related]
17. Combination of racial/ethnic and etiology/disease-specific factors is associated with lower survival following liver transplantation in African Americans: an analysis from UNOS/OPTN database.
Wong RJ; Ahmed A
Clin Transplant; 2014 Jul; 28(7):755-61. PubMed ID: 24750171
[TBL] [Abstract][Full Text] [Related]
18. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
Kim HS; Xiao X; Byun J; Jun G; DeSantis SM; Chen H; Thrift AP; El-Serag HB; Kanwal F; Amos CI
JAMA Netw Open; 2022 Oct; 5(10):e2234221. PubMed ID: 36190732
[TBL] [Abstract][Full Text] [Related]
20. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.
Kim D; Li AA; Perumpail BJ; Gadiparthi C; Kim W; Cholankeril G; Glenn JS; Harrison SA; Younossi ZM; Ahmed A
Hepatology; 2019 Mar; 69(3):1064-1074. PubMed ID: 30014489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
